Article Text

Download PDFPDF
SAT0421 Subclinical limited joint mobility in diabetic patients: A marker of micro-vascular complications
  1. A.J. Mathew1,
  2. K. Lavanya2,
  3. M. Hariharan2,
  4. D.J. Fernando3
  1. 1Department of Clinical Immunology and Rheumatology, Christian Medical College, Vellore, India, Vellore
  2. 2Indian Institute of Diabetes, Trivandrum, India
  3. 3Department of Diabetes and Endocrinology, Sherwood Forest Hospitals NHS Foundation Trust, Kings Mill Hospital, Sutton-in-Ashfield, United Kingdom

Abstract

Objectives To study the association of subclinical limited joint mobility (SLJM) with micro-vascular complications of type 2 diabetes mellitus (T2DM).

Methods T2DM patients from a tertiary care diabetic centre were compared with an equal number of age- and sex-matched non-diabetic controls from the community. Flexion and extension at the MCP and PIP joints of the non-dominant hand were measured in both groups using a validated finger goniometer. SLJM was defined as 2SD below the flexion and extension at MCP in the control group. Peripheral neuropathy (PN) was assessed using a standardized and validated screening test. Nephropathy (DN) was assessed using standardized dipsticks for microalbuminuria. Retinopathy (DR) was diagnosed and scored using a direct ophthalmoscope.

Results 236 cases and controls (Mean age: 50.7±12.2 years; 53.4% males) were analysed. The prevalence of cheiroarthropathy among the cases was 23.7%. SLJM (flexion) at the MCP and PIP joints were 42.8% and 50.3%, respectively and SLJM (extension) at the MCP was 37.3%. Table 1 gives the association of SLJM with variables. In regression analysis, PN and DN were the independent risk factors for SLJM.

Conclusions Goniometry may be proposed as a non-invasive and easily reproducible test for screening micro-vascular complications of T2DM in the community.

Disclosure of Interest None Declared

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.